STOCK-BASED EMPLOYEE COMPENSATION (Details) (USD $) In Thousands, except Share data, unless otherwise specified	6 Months Ended		3 Months Ended		6 Months Ended					0 Months Ended
	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014 Selling, General and Administrative Expenses [Member]	Jun. 30, 2013 Selling, General and Administrative Expenses [Member]	Jun. 30, 2014 Selling, General and Administrative Expenses [Member]	Jun. 30, 2013 Selling, General and Administrative Expenses [Member]	Jun. 30, 2014 Stock Options [Member]	Jun. 30, 2014 2013 Equity Incentive Plan [Member]	Feb. 27, 2013 2013 Equity Incentive Plan [Member]	May 12, 2014 2013 Equity Incentive Plan [Member] Stock Options [Member]	Apr. 30, 2014 2013 Equity Incentive Plan [Member] Stock Options [Member]	Feb. 27, 2013 2013 Equity Incentive Plan [Member] Stock Options [Member]	May 12, 2014 2013 Equity Incentive Plan [Member] Stock Options [Member]	Apr. 30, 2014 2013 Equity Incentive Plan [Member] Stock Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock authorized for issuance (in shares)									2,600,000
Options granted exercise right period												10 years
Stockholder ownership classification, for exercise price conditions (in hundredths)												10.00%
10% Stockholder exercise price of any option to fair value of common shares (in hundredths)												110.00%
Stock options granted (in shares)	865									25,000	840,000	850,000
Stock options, grants in period, exercise price (in dollars per share)	$ 1.44									$ 1.24	$ 1.44	$ 0.26
Grant date fair value										$ 24	$ 736	$ 151
Stock options exercisable period	9 years									2 years	2 years	2 years
Stock options expiration date										May 12, 2024	Apr. 30, 2024	Feb. 27, 2023
Option awards vesting on the date of issuance, 1 year after issuance and 2 years after issuance, respectively (in hundredths)												33.33%	33.33%	33.33%
Stock-based compensation expense			310	13	323	68
Number of options exercisable (in shares)								23,600
Intrinsic value of shares exercised								22
Common stock available for future issuance (in shares)							830,000
Assumptions used in estimating fair values of options granted [Abstract]
Expected volatility (in hundredths)	79.00%	84.00%
Expected dividend yield (in hundredths)	0.00%	0.00%
Weighted average risk-free interest rate (in hundredths)	1.81%	1.05%
Expected life	5 years 6 months	5 years 6 months
Forfeiture rate (in hundredths)	0.00%	0.00%
Unrecognized stock compensation expense	506
Unrecognized stock compensation expense (in years)	2 years
Number of Shares [Roll Forward]
Outstanding, Beginning balance (in shares)	905
Grants (in shares)	865									25,000	840,000	850,000
Exercised (in shares)	(23)
Forfeited, cancelled or expired (in shares)	0
Outstanding, Ending balance (in shares)	1,747
Exercisable (in shares)	854
Weighted Average Exercise Price [Roll Forward]
Outstanding, Beginning balance (in dollars per share)	$ 0.28
Grants (in dollars per share)	$ 1.44									$ 1.24	$ 1.44	$ 0.26
Exercised (in dollars per share)	$ (0.34)
Forfeited, cancelled or expired (in dollars per share)	$ 0
Outstanding, Ending balance (in dollars per share)	$ 0.85
Exercisable (in dollars per share)	$ 0.66
Options, Additional Disclosures [Abstract]
Outstanding, Remaining Contractual Life (in years)	9 years
Exercisable, Remaining Contractual Life (in years)	9 years									2 years	2 years	2 years
Outstanding, Aggregate Intrinsic Value	1,003
Exercisable, Aggregate Intrinsic Value	$ 647